Liquidia (LQDA) Operating Expenses (2020 - 2026)
Liquidia (LQDA) posted Operating Expenses of $86.2 million for Q2 2026, up 20.74% on a QoQ basis from $71.4 million in Q1 2026, and up 85.93% year-over-year from $46.3 million in Q2 2025.
Analysis
Liquidia (LQDA) Operating Expenses (2020 - 2026) Analysis & Trends
Liquidia has reported Operating Expenses for 7 years, with the latest figure at $86.2 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 85.93% year-over-year to $86.2 million in Q2 2026; TTM through Jun 2026 was $282.3 million, a 79.2% increase from a year earlier, with the FY2025 full-year figure at $209.7 million, up 55.0% from the prior year.
- Operating Expenses was $86.2 million for Q2 2026 at Liquidia, up from $71.4 million in the prior quarter.
- The five-year high for Operating Expenses was $86.2 million in Q2 2026, with the low at $11.9 million in Q4 2022.
- Average Operating Expenses over 5 years is $36.0 million, with a median of $31.4 million recorded in 2023.
- The largest YoY upside for Operating Expenses was 161.17% in 2023 against a maximum downside of 23.6% in 2023.
- Over 5 years, Operating Expenses stood at $11.9 million in 2022, then surged by 161.17% to $31.0 million in 2023, then advanced by 26.02% to $39.0 million in 2024, then surged by 85.1% to $72.2 million in 2025, then grew by 19.28% to $86.2 million in 2026.
- The last three Operating Expenses figures came in at $86.2 million (Q2 2026), $71.4 million (Q1 2026), and $72.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.46 Bn | 622.70 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 440.39 Bn | 433.82 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 44.36 Bn | 44.36 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Liquidia | 6.14 Bn | 5.85 Bn | 160.92 Mn | 86.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.16 Mn |
| Mar 31, 2026 | 71.36 Mn |
| Dec 31, 2025 | 72.23 Mn |
| Sep 30, 2025 | 52.58 Mn |
| Jun 30, 2025 | 46.34 Mn |
| Mar 31, 2025 | 38.55 Mn |
| Dec 31, 2024 | 39.02 Mn |
| Sep 30, 2024 | 33.64 Mn |
| Jun 30, 2024 | 30.86 Mn |
| Mar 31, 2024 | 31.77 Mn |
| Dec 31, 2023 | 30.97 Mn |
| Sep 30, 2023 | 18.57 Mn |
| Jun 30, 2023 | 27.61 Mn |
| Mar 31, 2023 | 13.73 Mn |
| Dec 31, 2022 | 11.86 Mn |
| Sep 30, 2022 | 12.00 Mn |
| Jun 30, 2022 | 12.89 Mn |
| Mar 31, 2022 | 17.96 Mn |
| Dec 31, 2021 | 14.58 Mn |
| Sep 30, 2021 | 10.26 Mn |